Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Jan 2025
USA
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
The U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class...
BioPharma, BioTech, Clinical Trials, Drug Approval, EMA, FDA, Healthcare Pharma Regulations, Pharma News, Regulatory Updates